Results obtained with cranial nerve block in the treatment of migraine in patients assisted in a reference hospital
Abstract
Introduction: The performance of Cranial nerve blocks (CNBs) in migraine has been increasingly used. CNBs are generally safe and well-tolerated procedures that can be performed in either emergency or outpatient settings. There is currently no guideline standardizing CNBs in migraine. In clinical practice, as well as the few published studies, the results are encouraging, justifying further studies in the area. Objectives: Evaluate the clinical response, safety and tolerability to the CNBs performed in patients with diagnostic criteria for migraine accompanying in the headache clinic in a reference hospital, and evaluate the response through objective scales (HIT 6 and EVA) evaluating comparatively pre and after application in a time interval of 60 days. Methods: Cross-sectional and retrospective observational clinical study in a convenience sample, in which the response to the CNBs performed in patients with migraine diagnostic criteria who accompany the headache clinic in a reference hospital, through the application of objective scales (HIT 6 and EVA) comparatively evaluating pre and after application in a time interval of 60 days, in the period from January 2021 to July 2022. Results: There were 15 patients included in the present study. The evaluation of the averages from EVA and HIT 6 pre and after application was statistically significant with P < 0.001. Only 6.66% (1) complained of some adverse effect such as initial insomnia. 93.33% (14) denied any post-application…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 15 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.